![]() |
||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||
![]() |
|
|||||||||||||||||||||||||||
| SBIRT Progress Hailed | Delaware Performance Based Contracting | |||||||||||||||||||||||||||
![]() |
|
|||||||||||||||||||||||||||
| Hot Topics | ||||||||||||||||||||||||||||
| OxyContin® Dependence Studied | TRI Hosts International Scholar: Visiting investigator from Greece delves into policy reform, quality improvement projects at TRI. Youth Drug Abuse: ONDCP launches new ad campaign aimed at teenagers. Adolescent Brain Development: Short report discusses still-developing brain segments, implications for drug effects on teens. Marlowe Joins NADCP: TRI Investigator to remain as Senior Consultant. Read announcement. Monitoring and Recovery: Monitoring instrument with associated intervention under development by John Cacciola, Ph.D. Contingency Management: TRI will evaluate cash versus non-cash contingency management protocols. Prevention Intervention for Adult Drug Court Patients: NIDA Behavioral Therapy Development grant will fund development of prevention intervention for low-risk, adult drug court clients. |
|||||||||||||||||||||||||||
TRI
study questions popularly held view that addiction to potent pain reliever
primarily strikes the drug “naïve.” More |
||||||||||||||||||||||||||||
| Jack Kemp Joins TRI | ||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||
| ©TRI 2006, Treatment Research Institute, 600 Public Ledger Building, 150 S. Independence Mall West, Philadelphia, PA 19106 (215) 399-0980 Directions Privacy Contact Us | ||||||||||||||||||||||||||||